ARCHIVES

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

AACR Completes List Of Symposia Chairpersons

April 22, 1988

Cancer Groups Criticize Prescription Drug Bills.

June 27, 2003

Varmus Pledges No Funding Gap for NCORP, Blames Snafu On “Unclear Communication”

April 11, 2014

DeVita To continue Discussions On Expanded Chops Despite ACCC Coolness; Would Go To DRCCA Board

March 27, 1981

NCA Okays Only A committee For Centers, Not New Division

May 29, 1987

House Bill Gives NCI $135 Million Increase, NIH $846 Million for FY 1988 Over 1987 Budgets

August 7, 1987